Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.

[1]  C. Hassan,et al.  Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement , 2020, Endoscopy.

[2]  S. Gross,et al.  Systematic review and meta-analysis of prevalence and risk factors for Barrett's esophagus. , 2019, Gastrointestinal endoscopy.

[3]  B. Jacobson,et al.  ASGE guideline on screening and surveillance of Barrett's esophagus. , 2019, Gastrointestinal endoscopy.

[4]  T. Raghunathan,et al.  Validation and Comparison of Tools for Selecting Individuals to Screen for Barrett's Esophagus and Early Neoplasia. , 2019, Gastroenterology.

[5]  P. Siersema,et al.  Endosheath ultrathin transnasal endoscopy is a cost-effective method for screening for Barrett's esophagus in patients with GERD symptoms. , 2019, Gastrointestinal endoscopy.

[6]  Sarmed S. Sami,et al.  Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  H. El‐Serag,et al.  Chemoprevention of Barrett’s oesophagus: a step closer with PPIs and aspirin , 2018, Nature Reviews Clinical Oncology.

[8]  Rui J. Costa,et al.  Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts. , 2018, Gastroenterology.

[9]  P. Moayyedi,et al.  Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial , 2018, The Lancet.

[10]  J. Inadomi,et al.  Screening and Surveillance for Barrett’s Esophagus: Is It Cost-Effective? , 2018, Digestive diseases and sciences.

[11]  Herbert C. Wolfsen,et al.  Highly Discriminant Methylated DNA Markers for the Non‐endoscopic Detection of Barrett's Esophagus , 2018, The American Journal of Gastroenterology.

[12]  A. Chak,et al.  The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. , 2018, Gastroenterology.

[13]  M. D’Silva,et al.  High-Percentage Pathological Findings in Obese Patients Suggest that Esophago-gastro-duodenoscopy Should Be Made Mandatory Prior to Bariatric Surgery , 2018, Obesity Surgery.

[14]  Hong Zhu,et al.  Epidemiology and Survival of Esophageal Cancer Patients in an American Cohort , 2018, Cureus.

[15]  K. Vega,et al.  Risk of histologic Barrett’s esophagus between African Americans and non-Hispanic whites: A meta-analysis , 2018, United European gastroenterology journal.

[16]  T. LaFramboise,et al.  Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett’s esophagus , 2018, Science Translational Medicine.

[17]  I. Dotan,et al.  Risk of Neoplastic Progression Among Patients with an Irregular Z Line on Long-Term Follow-Up , 2018, Digestive Diseases and Sciences.

[18]  J. Lagergren,et al.  The Epidemiology of Esophageal Adenocarcinoma. , 2017, Gastroenterology.

[19]  D. Schrag,et al.  The Impact of a Prior Diagnosis of Barrett’s Esophagus on Esophageal Adenocarcinoma Survival , 2017, The American Journal of Gastroenterology.

[20]  H. El‐Serag,et al.  External Validation of the Michigan Barrett's Esophagus Prediction Tool , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  P. Iyer,et al.  Putting it Through the Nose: The Ins and Outs of Transnasal Endoscopy , 2016, The American Journal of Gastroenterology.

[22]  Kenneth K Wang,et al.  Prevalence and Predictors of Gastroesophageal Reflux Complications in Community Subjects , 2016, Digestive Diseases and Sciences.

[23]  J. Birk,et al.  Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis , 2016, Journal of gastroenterology and hepatology.

[24]  J. Lagergren,et al.  The Male Predominance in Esophageal Adenocarcinoma. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  D. Schilling,et al.  Non-Physician Endoscopy: How Far Can We Go? , 2016, Visceral Medicine.

[26]  Nicholas J Shaheen,et al.  ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus , 2016, The American Journal of Gastroenterology.

[27]  Kenneth J. Chang,et al.  Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus. , 2015, Gastroenterology.

[28]  D. Metz,et al.  Adherence to the 2011 American Gastroenterological Association medical position statement for the diagnosis and management of Barrett's esophagus. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[29]  Nicholas J Shaheen,et al.  Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. , 2015, Gastroenterology clinics of North America.

[30]  M. Appleyard,et al.  Non-physician endoscopists: A systematic review. , 2015, World journal of gastroenterology.

[31]  R. Fitzgerald,et al.  Precision prevention of oesophageal adenocarcinoma , 2015, Nature Reviews Gastroenterology &Hepatology.

[32]  Sarmed S. Sami,et al.  Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  P. Moayyedi,et al.  Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial , 2015, Journal of medical screening.

[34]  Sarmed S. Sami,et al.  A Randomized Comparative Effectiveness Trial of Novel Endoscopic Techniques and Approaches for Barrett’s Esophagus Screening in the Community , 2015, The American Journal of Gastroenterology.

[35]  S. Chanock,et al.  Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. , 2014, Journal of the National Cancer Institute.

[36]  M. V. van Oijen,et al.  Familial clustering of Barrett's esophagus and esophageal adenocarcinoma in a European cohort. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[37]  F. Vleggaar,et al.  Surveillance of Barrett's Esophagus and Mortality from Esophageal Adenocarcinoma: A Population-Based Cohort Study , 2014, The American Journal of Gastroenterology.

[38]  H. El‐Serag,et al.  A multibiomarker risk score helps predict risk for Barrett's esophagus. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[39]  H. Welch,et al.  Repeated Upper Endoscopy in the Medicare Population , 2014, Annals of Internal Medicine.

[40]  H. El‐Serag,et al.  Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  Rebecca C Fitzgerald,et al.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus , 2013, Gut.

[42]  S. Spechler,et al.  Barrett esophagus and risk of esophageal cancer: a clinical review. , 2013, JAMA.

[43]  J. Andrici,et al.  Cigarette smoking and the risk of Barrett's esophagus: A systematic review and meta‐analysis , 2013, Journal of gastroenterology and hepatology.

[44]  J. Lagergren,et al.  Recent developments in esophageal adenocarcinoma , 2013, CA: a cancer journal for clinicians.

[45]  E. Schoon,et al.  Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. , 2013, Gastroenterology.

[46]  M. Solaymani-Dodaran,et al.  Cause-specific mortality of people with Barrett's esophagus compared with the general population: a population-based cohort study. , 2013, Gastroenterology.

[47]  J. Andrici,et al.  Hiatal hernia and the risk of Barrett's esophagus , 2013, Journal of gastroenterology and hepatology.

[48]  H. Morgenstern,et al.  Prediction of Barrett's Esophagus Among Men , 2013, The American Journal of Gastroenterology.

[49]  C. la Vecchia,et al.  A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[50]  P. Shekelle,et al.  Upper Endoscopy for Gastroesophageal Reflux Disease: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians , 2012, Annals of Internal Medicine.

[51]  H Brenner,et al.  Oesophageal cancer survival in Europe: a EUROCARE-4 study. , 2012, Cancer epidemiology.

[52]  Seth D. Crockett,et al.  Burden of gastrointestinal disease in the United States: 2012 update. , 2012, Gastroenterology.

[53]  Brett E. Bouma,et al.  Tethered capsule endomicroscopy enables less-invasive imaging of gastrointestinal tract microstructure , 2012, Nature Medicine.

[54]  H. Adami,et al.  A global assessment of the oesophageal adenocarcinoma epidemic , 2012, Gut.

[55]  A. Chak,et al.  Prevalence of Barrett Esophagus in First-Degree Relatives of Patients With Esophageal Adenocarcinoma , 2011, Journal of clinical gastroenterology.

[56]  H. Sørensen,et al.  Incidence of adenocarcinoma among patients with Barrett's esophagus. , 2011, The New England journal of medicine.

[57]  A. Rastogi,et al.  Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis. , 2011, Gastrointestinal endoscopy.

[58]  A. Zinsmeister,et al.  Epidemiology and Natural History of Intestinal Metaplasia of the Gastroesophageal Junction and Barrett's Esophagus: A Population-Based Study , 2011, The American Journal of Gastroenterology.

[59]  C. la Vecchia,et al.  Tobacco Smoking and Esophageal and Gastric Cardia Adenocarcinoma: A Meta-analysis , 2011, Epidemiology.

[60]  Prateek Sharma,et al.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus. , 2011, Gastroenterology.

[61]  D. Whiteman,et al.  Esophageal Adenocarcinoma Incidence in Individuals With Gastroesophageal Reflux: Synthesis and Estimates From Population Studies , 2011, The American Journal of Gastroenterology.

[62]  J. Emery,et al.  Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study , 2010, BMJ : British Medical Journal.

[63]  C. Abnet,et al.  Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. , 2010, Journal of the National Cancer Institute.

[64]  J. Rubenstein,et al.  Meta-Analyses of the Effect of Symptoms of Gastroesophageal Reflux on the Risk of Barrett's Esophagus , 2010, The American Journal of Gastroenterology.

[65]  Kenneth K Wang,et al.  Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. , 2009, Gastroenterology.

[66]  W. Chow,et al.  Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005 , 2009, British Journal of Cancer.

[67]  A. Chak,et al.  Receipt of Previous Diagnoses and Endoscopy and Outcome From Esophageal Adenocarcinoma: A Population-Based Study With Temporal Trends , 2009, The American Journal of Gastroenterology.

[68]  Hiroshi Mashimo,et al.  Radiofrequency ablation in Barrett's esophagus with dysplasia. , 2009, The New England journal of medicine.

[69]  M. Bronner,et al.  Risk Factors for Barrett's Esophagus Among Patients With Gastroesophageal Reflux Disease: A Community Clinic-Based Case–Control Study , 2009, The American Journal of Gastroenterology.

[70]  Nicholas J Shaheen,et al.  Barrett's oesophagus , 2009, The Lancet.

[71]  I. Russell,et al.  Cost effectiveness of nurse delivered endoscopy: findings from randomised multi-institution nurse endoscopy trial (MINuET) , 2009, BMJ : British Medical Journal.

[72]  Jeffrey S. Morris,et al.  Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis. , 2009, The Annals of thoracic surgery.

[73]  L. Gossner,et al.  Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus , 2008, Gut.

[74]  G. Block,et al.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus. , 2007, Gastroenterology.

[75]  Y. Romero.  Familial association in barrett esophagus. , 2007, Gastroenterology & hepatology.

[76]  A. Csendes,et al.  Endoscopic and Histologic Findings of the Foregut in 426 Patients with Morbid Obesity , 2007, Obesity surgery.

[77]  J. Brill,et al.  Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[78]  S. Hollis,et al.  A Randomized Controlled Trial Comparing the Accuracy of General Diagnostic Upper Gastrointestinal Endoscopy Performed by Nurse or Medical Endoscopists , 2006, Endoscopy.

[79]  Subhas Banerjee,et al.  Screening for Barrett's esophagus in asymptomatic women. , 2006, Gastrointestinal endoscopy.

[80]  H. Wolfsen,et al.  Barrett's Esophagus Is Common in Older Men and Women Undergoing Screening Colonoscopy Regardless of Reflux Symptoms , 2006, The American Journal of Gastroenterology.

[81]  Michael Vieth,et al.  Prevalence of Barrett's esophagus in the general population: an endoscopic study. , 2005, Gastroenterology.

[82]  D. Forman,et al.  Meta-Analysis A Systematic Review and Meta-Analysis of the Sex Ratio for Barrett’s Esophagus, Erosive Reflux Disease, and Nonerosive Reflux Disease , 2005 .

[83]  J. Connor,et al.  Barrett's esophagus in women: demographic features and progression to high-grade dysplasia and cancer. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[84]  D. Forman,et al.  Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus. , 2005, American journal of epidemiology.

[85]  M. Mayo,et al.  The frequency of Barrett's esophagus in high-risk patients with chronic GERD. , 2005, Gastrointestinal endoscopy.

[86]  A. Chak,et al.  Identification of Barrett's Esophagus in Relatives by Endoscopic Screening , 2004, The American Journal of Gastroenterology.

[87]  P. Groeneveld,et al.  Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[88]  G. Darling,et al.  Symptoms, acid exposure and motility in patients with Barrett's esophagus. , 2004, Canadian journal of surgery. Journal canadien de chirurgie.

[89]  O. Cummings,et al.  Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. , 2003, Gastroenterology.

[90]  J. Reynolds,et al.  Impaired visceral sensitivity to acid reflux in patients with Barrett's esophagus. the role of esophageal motility. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[91]  Christopher Y. Kim,et al.  Cost-effectiveness of screening a population with chronic gastroesophageal reflux. , 2003, Gastrointestinal endoscopy.

[92]  A. Fendrick,et al.  Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A CostUtility Analysis , 2003, Annals of Internal Medicine.

[93]  M. Sivak,et al.  Familial aggregation of Barrett’s oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults , 2002, Gut.

[94]  D. Schaid,et al.  Barrett's esophagus: prevalence in symptomatic relatives , 2002, American Journal of Gastroenterology.

[95]  D. Ransohoff,et al.  Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. , 2002, JAMA.

[96]  Robert Edson,et al.  Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux , 2001, American Journal of Gastroenterology.

[97]  M. Mayo,et al.  Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia , 2000, Gut.

[98]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[99]  A. Cameron.  Barrett's esophagus: prevalence and size of hiatal hernia , 1998, American Journal of Gastroenterology.

[100]  M. Helfand,et al.  Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. , 1997, The American journal of gastroenterology.

[101]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[102]  S. Spechler.  Barrett's esophagus , 1988, The New England journal of medicine.

[103]  W S Payne,et al.  The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. , 1985, The New England journal of medicine.

[104]  L. Sharples,et al.  Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus. , 2013, Gastroenterology.

[105]  J. Hagen,et al.  Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. , 2011, The Journal of thoracic and cardiovascular surgery.

[106]  A. Neugut,et al.  Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[107]  Sushovan Guha,et al.  Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. , 2002, Gastroenterology.